Phivida Goes Public, Looks to Become a Leader in Hemp-based CBDs


Ryan Allway

December 19th, 2017

Exclusive, News, Top Story


The cannabidiol (CBD) industry is projected to top $2 billion in revenue by 2020, according to the Hemp Business Journal, which represents a 700% increase over the prior years. While the wider cannabis industry is poised to exceed $50 billion, the market for cannabidiol-based products represents the fastest growing subset of the industry. Researchers have also become increasingly interested in the cannabinoid’s therapeutic potential.

In this article, we will look at Phivida Holdings Inc. (CSE:VIDA) and its unique approach to developing a wide range of CBD products across several market segments. The company begins trading today, December 19, on the Canadian Securities Exchange under the ticker symbol VIDA.

CBDs Show Strong Potential

Researchers have become increasingly interested in CBDs since Charlotte’s Web became widely popular for treating childhood epilepsy. According to Google Scholar, there have been more than 2,000 papers published about CBD this year alone. Many companies have also become increasingly interested in the therapeutic potential for the cannabinoid, as evidenced by the more than 1,600 U.S. patents that have been issued mentioning CBD.

The strong interest in CBD research has also fueled increasing demand among consumers for over-the-counter CBD products. Google Trends shows a significant increase in search activity for terms like “CBD oil” as consumers seek out supplements to improve their health. Most of this demand comes from the United States, Canada, and certain parts of Europe, and the growth in search traffic and interest has shown no signs of abating.

In addition to interest in CBD, the wider functional food and beverage industry continues to capture market share from traditional beverage products like soft drinks. Consumers are seeking healthier options to conventional beverages that contain sugar or artificial sweeteners, which includes iced teas, vitamin waters, and related products. CBD products could play a big role in this emerging category as researchers continue to uncover their benefits.

Last month, the Canadian government officially legalized cannabinoid-infused foods and beverages across the country. The news comes shortly after the beverage giant Constellation Brands (NASDAQ: STZ) announced a 9.9% investment in Canopy Growth Corp. (TSX: WEED), a leading licensed producer of medical cannabis in Canada. The move supports both the CBD and THC sides of the cannabis industry and opens the door to further investment.

The World Anti-Doping Agency (WADA) also removed CBD from its Prohibited Substances List as of January 1, 2018. This means that athletes around the world can benefit from the anti-inflammatory, antioxidant, and neuroprotective benefits of CBD supplements without worrying about consequences from antiquated cannabinoid laws. The use of CBD supplements by athletes could also generate more widespread awareness of the benefits.

Consumer CBD Products

Phivida – which combines “Phi” (the golden ratio) with “Vida” (the philosophy of valuing happiness) – is focused on developing all-natural, whole-plant products that provide consumers with access to the benefits of CBDs in the most palatable way.

The company has pioneered innovative consumer CBD products, including sweet iced teas, vitamin juices, and vitamin shots, that make the cannabinoid much more accessible to the average person than raw oils. In addition to its consumer line, the company has developed clinical CBD oil tinctures for integrated healthcare professionals to dispense to their patients and wholesale CBD oil products to support the industry’s growth.

By focusing on these markets, the company provides investors with exposure to both the rapidly growing market for CBD supplements and the rapidly growing functional food and beverage industry.

Phivida recently closed an oversubscribed IPO – without the use of a reverse takeover or shell company. The company initiates trading today on the Canadian Securities Exchange under the ticker symbol “VIDA”. This means that investors have access to a very clean cap table and company with a unique approach to the industry.

Looking Ahead

Phivida Holdings Inc. (CSE: VIDA) represents a compelling opportunity within the burgeoning CBD industry with consumer, healthcare-focused, and wholesale product lines. Recent acceptance of CBD by both the Canadian government and the WADA bodes well for further growth in the industry. Meanwhile, today’s IPO is the first full prospective IPO in the Canadian cannabis industry and appears well positioned for near-term growth.

For more information, visit the company’s website.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading